NEW YORK--(BUSINESS WIRE)--Massive Bio, a leading artificial intelligence (AI) analytics company specializing in precision oncology, has been selected by the Precision Cancer Consortium (PCC), a ...
Trial records are sourced from ClinicalTrials.gov and indexed using natural language processing techniques, including named entity recognition, term normalization, and relationship extraction.
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, today announced its participation in the Molecular Analysis for Combination ...
Ahead of World Duchenne Awareness Day, myTomorrows celebrates referring more than 600 Duchenne muscular dystrophy patients to clinical trials and expanded access programs with its precision matching ...
Chicago, Monday, June 4, 2018 -- The National Cancer Institute's Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has achieved a milestone ...
Comparing Active Surveillance and Watchful Waiting With Radical Treatment Using Machine Learning Models Among Patients With Prostate Cancer Matching patients with cancer to precision medicine clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback